A citation-based method for searching scientific literature

Andrea de Bartolomeis, Camilla Avagliano, Licia Vellucci, Luigi D'Ambrosio, Mirko Manchia, Giordano D'Urso, Elisabetta Filomena Buonaguro, Felice Iasevoli. Neurosci Biobehav Rev 2019
Times Cited: 12







List of co-cited articles
193 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Glycine Signaling in the Framework of Dopamine-Glutamate Interaction and Postsynaptic Density. Implications for Treatment-Resistant Schizophrenia.
Andrea de Bartolomeis, Mirko Manchia, Federica Marmo, Licia Vellucci, Felice Iasevoli, Annarita Barone. Front Psychiatry 2020
14
41

Progressive recruitment of cortical and striatal regions by inducible postsynaptic density transcripts after increasing doses of antipsychotics with different receptor profiles: insights for psychosis treatment.
Andrea de Bartolomeis, Felice Iasevoli, Federica Marmo, Elisabetta F Buonaguro, Anna Eramo, Rodolfo Rossi, Livia Avvisati, Gianmarco Latte, Carmine Tomasetti. Eur Neuropsychopharmacol 2015
19
33

Dopamine synthesis capacity in patients with treatment-resistant schizophrenia.
Arsime Demjaha, Robin M Murray, Philip K McGuire, Shitij Kapur, Oliver D Howes. Am J Psychiatry 2012
231
33

Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology.
Oliver D Howes, Rob McCutcheon, Ofer Agid, Andrea de Bartolomeis, Nico J M van Beveren, Michael L Birnbaum, Michael A P Bloomfield, Rodrigo A Bressan, Robert W Buchanan, William T Carpenter,[...]. Am J Psychiatry 2017
431
33

Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study.
Ryosuke Tarumi, Sakiko Tsugawa, Yoshihiro Noda, Eric Plitman, Shiori Honda, Karin Matsushita, Sofia Chavez, Kyosuke Sawada, Masataka Wada, Mie Matsui,[...]. Neuropsychopharmacology 2020
24
33

Modulation of glutamatergic functional connectivity by a prototypical antipsychotic: Translational inference from a postsynaptic density immediate-early gene-based network analysis.
Annarita Barone, Simona Signoriello, Gianmarco Latte, Licia Vellucci, Giuseppe Giordano, Camilla Avagliano, Elisabetta F Buonaguro, Federica Marmo, Carmine Tomasetti, Felice Iasevoli,[...]. Behav Brain Res 2021
6
66

Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis.
Andrea de Bartolomeis, Chiara Sarappa, Elisabetta F Buonaguro, Federica Marmo, Anna Eramo, Carmine Tomasetti, Felice Iasevoli. Prog Neuropsychopharmacol Biol Psychiatry 2013
53
33

Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular Actions.
Carmine Tomasetti, Felice Iasevoli, Elisabetta Filomena Buonaguro, Domenico De Berardis, Michele Fornaro, Annastasia Lucia Carmela Fiengo, Giovanni Martinotti, Laura Orsolini, Alessandro Valchera, Massimo Di Giannantonio,[...]. Int J Mol Sci 2017
40
33

The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research.
Steven G Potkin, John M Kane, Christoph U Correll, Jean-Pierre Lindenmayer, Ofer Agid, Stephen R Marder, Mark Olfson, Oliver D Howes. NPJ Schizophr 2020
95
33


Dopamine receptor subtypes contribution to Homer1a induction: insights into antipsychotic molecular action.
Felice Iasevoli, Carmine Tomasetti, Alberto Ambesi-Impiombato, Giovanni Muscettola, Andrea de Bartolomeis. Prog Neuropsychopharmacol Biol Psychiatry 2009
37
25

Distinct roles for different Homer1 isoforms in behaviors and associated prefrontal cortex function.
Kevin D Lominac, Erik B Oleson, Matthew Pava, Matthias Klugmann, Martin K Schwarz, Peter H Seeburg, Matthew J During, Paul F Worley, Peter W Kalivas, Karen K Szumlinski. J Neurosci 2005
99
25

Divergent acute and chronic modulation of glutamatergic postsynaptic density genes expression by the antipsychotics haloperidol and sertindole.
Felice Iasevoli, Carmine Tomasetti, Federica Marmo, Daniele Bravi, Jørn Arnt, Andrea de Bartolomeis. Psychopharmacology (Berl) 2010
40
25

Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia.
Davide Amato, Anna Kruyer, Anne-Noël Samaha, Andreas Heinz. Front Psychiatry 2019
25
25


Differential expression of Homer 1 gene by acute and chronic administration of antipsychotics and dopamine transporter inhibitors in the rat forebrain.
Alberto Ambesi-Impiombato, Fabio Panariello, Carmela Dell'aversano, Carmine Tomasetti, Giovanni Muscettola, Andrea de Bartolomeis. Synapse 2007
33
25

Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function.
Arsime Demjaha, Alice Egerton, Robin M Murray, Shitij Kapur, Oliver D Howes, James M Stone, Philip K McGuire. Biol Psychiatry 2014
209
25

Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive.
Elias Mouchlianitis, Michael A P Bloomfield, Vincent Law, Katherine Beck, Sudhakar Selvaraj, Naresh Rasquinha, Adam Waldman, Federico E Turkheimer, Alice Egerton, James Stone,[...]. Schizophr Bull 2016
121
25

Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones.
Felice Iasevoli, Sara Giordano, Raffaele Balletta, Gianmarco Latte, Maria Vittoria Formato, Emiliano Prinzivalli, Domenico De Berardis, Carmine Tomasetti, Andrea de Bartolomeis. Prog Neuropsychopharmacol Biol Psychiatry 2016
77
25


Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [18F]DOPA PET Study.
Euitae Kim, Oliver D Howes, Mattia Veronese, Katherine Beck, Seongho Seo, Jin Woo Park, Jae Sung Lee, Yun-Sang Lee, Jun Soo Kwon. Neuropsychopharmacology 2017
70
25

A dopaminergic mechanism of antipsychotic drug efficacy, failure, and failure reversal: the role of the dopamine transporter.
Davide Amato, Fabio Canneva, Paul Cumming, Simone Maschauer, Dominik Groos, Jana Katharina Dahlmanns, Teja W Grömer, Lisa Chiofalo, Marc Dahlmanns, Fang Zheng,[...]. Mol Psychiatry 2020
35
25

White matter microstructure and structural networks in treatment-resistant schizophrenia patients after commencing clozapine treatment: A longitudinal diffusion imaging study.
Giulia Tronchin, Genevieve McPhilemy, Mohamed Ahmed, Liam Kilmartin, Laura Costello, Natalie J Forde, Leila Nabulsi, Theophilus N Akudjedu, Laurena Holleran, Brian Hallahan,[...]. Psychiatry Res 2021
4
75

Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia.
Stephen K Brannan, Sharon Sawchak, Andrew C Miller, Jeffrey A Lieberman, Steven M Paul, Alan Breier. N Engl J Med 2021
50
25

Effects of the antipsychotics haloperidol, clozapine, and aripiprazole on the dendritic spine.
Manabu Takaki, Masafumi Kodama, Yutaka Mizuki, Hiroki Kawai, Bunta Yoshimura, Makiko Kishimoto, Shinji Sakamoto, Yuko Okahisa, Norihito Yamada. Eur Neuropsychopharmacol 2018
11
27





Homer 1a gene expression modulation by antipsychotic drugs: involvement of the glutamate metabotropic system and effects of D-cycloserine.
Daniela Polese, Antonella Amato de Serpis, Alberto Ambesi-Impiombato, Giovanni Muscettola, Andrea de Bartolomeis. Neuropsychopharmacology 2002
59
25

NMDA receptor hypofunction model of schizophrenia.
J W Olney, J W Newcomer, N B Farber. J Psychiatr Res 1999
718
25

Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, Added to Clozapine for the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial.
Chieh-Hsin Lin, Ching-Hua Lin, Yue-Cune Chang, Yu-Jhen Huang, Po-Wei Chen, Hui-Ting Yang, Hsien-Yuan Lane. Biol Psychiatry 2018
65
25

Treatment-resistant schizophrenia: Addressing white matter integrity, intracortical glutamate levels, clinical and cognitive profiles between early- and adult-onset patients.
Marta Matrone, Georgios D Kotzalidis, Andrea Romano, Alessandro Bozzao, Ilaria Cuomo, Francesca Valente, Chiara Gabaglio, Ginevra Lombardozzi, Giada Trovini, Emanuela Amici,[...]. Prog Neuropsychopharmacol Biol Psychiatry 2022
5
60


Clinical Course, Neurobiology and Therapeutic Approaches to Treatment Resistant Schizophrenia. Toward an Integrated View.
Cheryl Cheuk-Yan Leung, Romayne Gadelrab, Chukwuma Uchenna Ntephe, Philip K McGuire, Arsime Demjaha. Front Psychiatry 2019
11
18

Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies.
P Fusar-Poli, R Smieskova, M J Kempton, B C Ho, N C Andreasen, S Borgwardt. Neurosci Biobehav Rev 2013
332
16

Functional neuroimaging in treatment resistant schizophrenia: A systematic review.
Cinzia Molent, Daniele Olivo, Robert Christian Wolf, Matteo Balestrieri, Fabio Sambataro. Neurosci Biobehav Rev 2019
13
16

Homer proteins: implications for neuropsychiatric disorders.
Karen K Szumlinski, Peter W Kalivas, Paul F Worley. Curr Opin Neurobiol 2006
135
16

Ventral tegmental area/midbrain functional connectivity and response to antipsychotic medication in schizophrenia.
Jennifer A Hadley, Rodolphe Nenert, Nina V Kraguljac, Mark S Bolding, David M White, Frank M Skidmore, Kristina M Visscher, Adrienne C Lahti. Neuropsychopharmacology 2014
117
16

The postsynaptic architecture of excitatory synapses: a more quantitative view.
Morgan Sheng, Casper C Hoogenraad. Annu Rev Biochem 2007
667
16

The Homer family proteins.
Yoko Shiraishi-Yamaguchi, Teiichi Furuichi. Genome Biol 2007
224
16

Change in brain network topology as a function of treatment response in schizophrenia: a longitudinal resting-state fMRI study using graph theory.
Jennifer Ann Hadley, Nina Vanessa Kraguljac, David Matthew White, Lawrence Ver Hoef, Janell Tabora, Adrienne Carol Lahti. NPJ Schizophr 2016
62
16

Changes in brain functional connectivity after chronic haloperidol in rats: a network analysis.
Anne L Wheeler, Meaghan C Creed, Aristotle N Voineskos, José N Nobrega. Int J Neuropsychopharmacol 2014
13
16

The Effects of Antipsychotics on the Synaptic Plasticity Gene Homer1a Depend on a Combination of Their Receptor Profile, Dose, Duration of Treatment, and Brain Regions Targeted.
Felice Iasevoli, Elisabetta Filomena Buonaguro, Camilla Avagliano, Annarita Barone, Anna Eramo, Licia Vellucci, Andrea de Bartolomeis. Int J Mol Sci 2020
4
50

Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses.
J Lally, O Ajnakina, M Di Forti, A Trotta, A Demjaha, A Kolliakou, V Mondelli, T Reis Marques, C Pariante, P Dazzan,[...]. Psychol Med 2016
152
16



Disease Severity in Treatment Resistant Schizophrenia Patients Is Mainly Affected by Negative Symptoms, Which Mediate the Effects of Cognitive Dysfunctions and Neurological Soft Signs.
Felice Iasevoli, Camilla Avagliano, Benedetta Altavilla, Annarita Barone, Luigi D'Ambrosio, Marta Matrone, Danilo Notar Francesco, Eugenio Razzino, Andrea de Bartolomeis. Front Psychiatry 2018
17
16

Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors.
A Demjaha, J M Lappin, D Stahl, M X Patel, J H MacCabe, O D Howes, M Heslin, U A Reininghaus, K Donoghue, B Lomas,[...]. Psychol Med 2017
135
16

Glutamatergic neurometabolites in clozapine-responsive and -resistant schizophrenia.
Meghan Elizabeth Goldstein, Valerie Margaret Anderson, Avinesh Pillai, Robert R Kydd, Bruce R Russell. Int J Neuropsychopharmacol 2015
64
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.